NASDAQ:LINE • US53566V1061
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LINEAGE INC (LINE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | Truist Securities | Maintains | Buy -> Buy |
| 2026-03-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-03-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-02 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-27 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-02-26 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-01-13 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2026-01-09 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-01-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-18 | Baird | Downgrade | Outperform -> Neutral |
| 2025-12-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-11-14 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-11-12 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-11-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-11-06 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-11-06 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-10-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-06 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-09-23 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-09-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.342B 8.38% | 5.34B -0.03% | 5.355B 0.28% | 5.579B 4.18% | 5.76B 3.24% | 4.74B -17.71% | 6.75B 42.41% | 7.626B 12.98% | |
| EBITDA YoY % growth | 1.25B 18.34% | 1.223B -2.15% | 1.147B -6.21% | 1.232B 7.41% | 1.299B 5.44% | 1.414B 8.85% | 1.412B -0.14% | N/A | |
| EBIT YoY % growth | 490.2M 29.34% | 347M -29.21% | 252M -27.38% | 276.55M 9.74% | 348.33M 25.96% | 575.99M 65.36% | 523.36M -9.14% | 614.96M 17.50% | |
| Operating Margin | 9.18% | 6.50% | 4.71% | 4.96% | 6.05% | 12.15% | 7.75% | 8.06% | |
| EPS YoY % growth | N/A | N/A | -0.44 84.71% | -0.74 -69.30% | -0.66 10.25% | -0.65 1.23% | -0.17 73.44% | 0.09 152.94% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 -143.00% | -0.18 -123.13% | -0.06 82.06% | -0.07 -183.11% | -0.18 11.11% | -0.17 2.86% | -0.15 -136.85% | -0.15 -104.55% |
| Revenue Q2Q % growth | 1.349B 4.41% | 1.394B 3.26% | 1.439B 4.50% | 1.462B 9.43% | 1.415B 4.89% | 1.464B 5.02% | 1.488B 3.41% | 1.473B 0.75% |
| EBITDA Q2Q % growth | 290.78M 10.98% | 305.76M -38.73% | 328.7M -55.34% | 348.64M -63.80% | 328.08M 12.83% | 340.17M 11.25% | 360.41M 9.65% | 351.89M 0.93% |
| EBIT Q2Q % growth | 53.402M 6.80% | 65.927M 4.65% | 79.202M 13.15% | 99.687M 46.60% | 71.007M 32.97% | 75.087M 13.89% | 98.593M 24.48% | 103.15M 3.47% |
All data in USD
25 analysts have analysed LINE and the average price target is 40.4 USD. This implies a price decrease of -0.16% is expected in the next year compared to the current price of 40.47.
LINEAGE INC (LINE) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of LINEAGE INC (LINE) is -0.21 USD and the consensus revenue estimate is 1.35B USD.
The consensus rating for LINEAGE INC (LINE) is 67.2 / 100 . This indicates that analysts generally have a neutral outlook on the stock.